CEO Dave Rosa in the Feb newsletter set about some milestones/targets for Q1 and Q2. Can we expect announcements on their achievement or delay soon?
1. Feedback from European regulatory auth on Design Dossier (by end Feb)
2. Receive CE mark - by end Q2.
3. Discuss design of US Pivotal Trial with FDA - by Feb.
I might email the company and ask them re progress.
Thnx
ts
Add to My Watchlist
What is My Watchlist?